The association of plasma levels of liver enzymes and risk of gestational diabetes mellitus: a systematic review and dose-response meta-analysis of observational studies

Wei Zhao; Li Zhang; Guoliang Zhang; Hamed Kord Varkaneh; Jamal Rahmani; Cain Clark; Paul M Ryan; Hebatullah M Abdulazeem; Ammar Salehisahlabadi

doi:10.1007/s00592-019-01458-8

The association of plasma levels of liver enzymes and risk of gestational diabetes mellitus: a systematic review and dose-response meta-analysis of observational studies

Wei Zhao, Li Zhang, Guoliang Zhang, Hamed Kord Varkaneh, Jamal Rahmani, Cain Clark, Paul M Ryan, Hebatullah M Abdulazeem, Ammar Salehisahlabadi

Research output: Contribution to journal › Review article › peer-review

15 Citations (Scopus)

174 Downloads (Pure)

Abstract

Aims: Relationship between liver enzymes such as gamma-glutamyl transferase (GGT), alanine aminotransferase (ALT), aspartate transaminase (AST) and alkaline phosphatase and risk of gestational diabetes mellitus (GDM) is a controversial issue. The aim of this systematic review and dose–response meta-analysis was to investigate the association between liver enzymes and risk of GDM in observational studies. Methods: A comprehensive systematic literature search was conducted in MEDLINE/PubMed, SCOPUS and Web of Science databases up to September 2019. Combined odds ratios (ORs) with 95% confidence intervals (CIs) were evaluated by DerSimonian and Laird random-effects models. Dose–response analyses of these relationships were also carried out. Results: Eight studies with 25,451 participants containing 2549 cases were included in this study. Pooled results showed a significant association between GGT levels and risk of GDM (OR 2.10, 95% CI 1.14–3.86, I ² 84%). In addition, random-effects model indicated a dramatic and direct significant association between GGT and risk of GDM in nonlinear (p < 0.001) and linear (p < 0.001) dose–response analysis. Associations between ALT and AST with risk of GDM were found to be non-significant (OR 1.32, 95% CI 0.91–1.90, I ² 65% and OR 0.76, 95% CI 0.52–1.10, I ² 16%, respectively). Conclusion: This systematic review and dose–response meta-analysis highlights GGT as a significant and robust predictor of the incidence of GDM in pregnant women.

Original language	English
Pages (from-to)	635–644
Number of pages	10
Journal	Acta Diabetologica
Volume	57
Issue number	6
Early online date	28 Nov 2019
DOIs	https://doi.org/10.1007/s00592-019-01458-8
Publication status	Published - 1 Jun 2020

Bibliographical note

The final publication is available at Springer via http://dx.doi.org/10.1007/s00592-019-01458-8

Copyright © and Moral Rights are retained by the author(s) and/ or other copyright owners. A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. This item cannot be reproduced or quoted extensively from without first obtaining permission in writing from the copyright holder(s). The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the copyright holders.

Keywords

Gamma-glutamyl transferase
Gestational diabetes mellitus
Liver enzymes

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Endocrinology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00592-019-01458-8

Post-PrintAccepted author manuscript, 818 KBLicence: Unspecified

Cite this

Zhao, W., Zhang, L., Zhang, G., Varkaneh, H. K., Rahmani, J., Clark, C., Ryan, P. M., Abdulazeem, H. M., & Salehisahlabadi, A. (2020). The association of plasma levels of liver enzymes and risk of gestational diabetes mellitus: a systematic review and dose-response meta-analysis of observational studies. Acta Diabetologica, 57(6), 635–644. https://doi.org/10.1007/s00592-019-01458-8

Zhao, W, Zhang, L, Zhang, G, Varkaneh, HK, Rahmani, J, Clark, C, Ryan, PM, Abdulazeem, HM & Salehisahlabadi, A 2020, 'The association of plasma levels of liver enzymes and risk of gestational diabetes mellitus: a systematic review and dose-response meta-analysis of observational studies', Acta Diabetologica, vol. 57, no. 6, pp. 635–644. https://doi.org/10.1007/s00592-019-01458-8

@article{98c0c8344c854ca28f61c91d10f52613,

title = "The association of plasma levels of liver enzymes and risk of gestational diabetes mellitus: a systematic review and dose-response meta-analysis of observational studies",

abstract = "Aims: Relationship between liver enzymes such as gamma-glutamyl transferase (GGT), alanine aminotransferase (ALT), aspartate transaminase (AST) and alkaline phosphatase and risk of gestational diabetes mellitus (GDM) is a controversial issue. The aim of this systematic review and dose–response meta-analysis was to investigate the association between liver enzymes and risk of GDM in observational studies. Methods: A comprehensive systematic literature search was conducted in MEDLINE/PubMed, SCOPUS and Web of Science databases up to September 2019. Combined odds ratios (ORs) with 95% confidence intervals (CIs) were evaluated by DerSimonian and Laird random-effects models. Dose–response analyses of these relationships were also carried out. Results: Eight studies with 25,451 participants containing 2549 cases were included in this study. Pooled results showed a significant association between GGT levels and risk of GDM (OR 2.10, 95% CI 1.14–3.86, I 2 84%). In addition, random-effects model indicated a dramatic and direct significant association between GGT and risk of GDM in nonlinear (p < 0.001) and linear (p < 0.001) dose–response analysis. Associations between ALT and AST with risk of GDM were found to be non-significant (OR 1.32, 95% CI 0.91–1.90, I 2 65% and OR 0.76, 95% CI 0.52–1.10, I 2 16%, respectively). Conclusion: This systematic review and dose–response meta-analysis highlights GGT as a significant and robust predictor of the incidence of GDM in pregnant women. ",

keywords = "Gamma-glutamyl transferase, Gestational diabetes mellitus, Liver enzymes",

author = "Wei Zhao and Li Zhang and Guoliang Zhang and Varkaneh, {Hamed Kord} and Jamal Rahmani and Cain Clark and Ryan, {Paul M} and Abdulazeem, {Hebatullah M} and Ammar Salehisahlabadi",

note = "The final publication is available at Springer via http://dx.doi.org/10.1007/s00592-019-01458-8 Copyright {\textcopyright} and Moral Rights are retained by the author(s) and/ or other copyright owners. A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. This item cannot be reproduced or quoted extensively from without first obtaining permission in writing from the copyright holder(s). The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the copyright holders. ",

year = "2020",

month = jun,

day = "1",

doi = "10.1007/s00592-019-01458-8",

language = "English",

volume = "57",

pages = "635–644",

journal = "Acta Diabetologica",

issn = "1432-5233",

publisher = "Springer",

number = "6",

}

TY - JOUR

T1 - The association of plasma levels of liver enzymes and risk of gestational diabetes mellitus

T2 - a systematic review and dose-response meta-analysis of observational studies

AU - Zhao, Wei

AU - Zhang, Li

AU - Zhang, Guoliang

AU - Varkaneh, Hamed Kord

AU - Rahmani, Jamal

AU - Clark, Cain

AU - Ryan, Paul M

AU - Abdulazeem, Hebatullah M

AU - Salehisahlabadi, Ammar

N1 - The final publication is available at Springer via http://dx.doi.org/10.1007/s00592-019-01458-8 Copyright © and Moral Rights are retained by the author(s) and/ or other copyright owners. A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. This item cannot be reproduced or quoted extensively from without first obtaining permission in writing from the copyright holder(s). The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the copyright holders.

PY - 2020/6/1

Y1 - 2020/6/1

N2 - Aims: Relationship between liver enzymes such as gamma-glutamyl transferase (GGT), alanine aminotransferase (ALT), aspartate transaminase (AST) and alkaline phosphatase and risk of gestational diabetes mellitus (GDM) is a controversial issue. The aim of this systematic review and dose–response meta-analysis was to investigate the association between liver enzymes and risk of GDM in observational studies. Methods: A comprehensive systematic literature search was conducted in MEDLINE/PubMed, SCOPUS and Web of Science databases up to September 2019. Combined odds ratios (ORs) with 95% confidence intervals (CIs) were evaluated by DerSimonian and Laird random-effects models. Dose–response analyses of these relationships were also carried out. Results: Eight studies with 25,451 participants containing 2549 cases were included in this study. Pooled results showed a significant association between GGT levels and risk of GDM (OR 2.10, 95% CI 1.14–3.86, I 2 84%). In addition, random-effects model indicated a dramatic and direct significant association between GGT and risk of GDM in nonlinear (p < 0.001) and linear (p < 0.001) dose–response analysis. Associations between ALT and AST with risk of GDM were found to be non-significant (OR 1.32, 95% CI 0.91–1.90, I 2 65% and OR 0.76, 95% CI 0.52–1.10, I 2 16%, respectively). Conclusion: This systematic review and dose–response meta-analysis highlights GGT as a significant and robust predictor of the incidence of GDM in pregnant women.

AB - Aims: Relationship between liver enzymes such as gamma-glutamyl transferase (GGT), alanine aminotransferase (ALT), aspartate transaminase (AST) and alkaline phosphatase and risk of gestational diabetes mellitus (GDM) is a controversial issue. The aim of this systematic review and dose–response meta-analysis was to investigate the association between liver enzymes and risk of GDM in observational studies. Methods: A comprehensive systematic literature search was conducted in MEDLINE/PubMed, SCOPUS and Web of Science databases up to September 2019. Combined odds ratios (ORs) with 95% confidence intervals (CIs) were evaluated by DerSimonian and Laird random-effects models. Dose–response analyses of these relationships were also carried out. Results: Eight studies with 25,451 participants containing 2549 cases were included in this study. Pooled results showed a significant association between GGT levels and risk of GDM (OR 2.10, 95% CI 1.14–3.86, I 2 84%). In addition, random-effects model indicated a dramatic and direct significant association between GGT and risk of GDM in nonlinear (p < 0.001) and linear (p < 0.001) dose–response analysis. Associations between ALT and AST with risk of GDM were found to be non-significant (OR 1.32, 95% CI 0.91–1.90, I 2 65% and OR 0.76, 95% CI 0.52–1.10, I 2 16%, respectively). Conclusion: This systematic review and dose–response meta-analysis highlights GGT as a significant and robust predictor of the incidence of GDM in pregnant women.

KW - Gamma-glutamyl transferase

KW - Gestational diabetes mellitus

KW - Liver enzymes

UR - http://www.scopus.com/inward/record.url?scp=85075687458&partnerID=8YFLogxK

U2 - 10.1007/s00592-019-01458-8

DO - 10.1007/s00592-019-01458-8

M3 - Review article

C2 - 31781958

SN - 1432-5233

VL - 57

SP - 635

EP - 644

JO - Acta Diabetologica

JF - Acta Diabetologica

IS - 6

ER -

The association of plasma levels of liver enzymes and risk of gestational diabetes mellitus: a systematic review and dose-response meta-analysis of observational studies

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this